SNSoren Naaby-Hansen

Soren Naaby-Hansen

*This is an algorithmically generated author record based on publicly available information.

Soren Naaby-Hansen has a total of 17 co-authors. Here are the top co-authors by number of shared publications:

  • Rainer Cramer

    Department of Chemistry University of Reading Reading UK

    3 shared publications
  • Akunna Akpan

    Ludwig Institute for Cancer Research, Royal Free and University College London Medical School, 91 Riding House Street, London W1W 7BS, UK

    2 shared publications
  • Claire Hastie

    Prostate Cancer Research Centre, Royal Free and University College London Medical School, UK

    2 shared publications
  • John R Masters

    Prostate Cancer Research Centre, Royal Free and University College London Medical School, 91 Riding House Street, London W1W 7EJ, UK

    2 shared publications
  • Kohji Nagano

    Ludwig Institute for Cancer Research, Royal Free and University College London, Medical School, London, UK

    2 shared publications
  • Alan Entwistle

    Ludwig Institute for Cancer Research, Royal Free and University College London, Medical School, London, UK

    1 shared publication

Latest Publications

  • Open Access

    PDGF regulates the actin cytoskeleton through hnRNP‐K‐mediated activation of the ubiquitin E3‐ligase MIR

    by Kohji Nagano, Beat C Bornhauser, Gayathri Warnasuriya, Alan Entwistle, Rainer Cramer, Dan Lindholm, Soren Naaby‐Hansen

    PDGF is a potent chemotactic mitogen and a strong inductor of fibroblast motility. In Swiss 3T3 fibroblasts, exposure to PDGF but not EGF or IGF‐1 causes a rapid loss of actin stress fibers (SFs) and focal adhesions (FAs), which is followed by the development of retractile dendritic protrusions and induction of motility. The PDGF‐specific actin reorganization was blocked by inhibition of Src‐kinase and the 26S proteasome. PDGF induced Src‐dependent association between the multifunctional transcription/translation regulator hnRNP‐K and the mRNA‐encoding myosin regulatory light‐chain (MRLC)‐interacting protein (MIR), a E3‐ubiquitin ligase that is MRLC specific. This in turn rapidly increased MIR expression, and led to ubiquitination and proteasome‐mediated degradation of MRLC. Downregulation of MIR by RNA muting prevented the reorganization of actin structures and severely reduced the migratory and wound‐healing potential of PDGF‐treated cells. The results show that activation of MIR and the resulting removal of diphosphorylated MRLC are essential for PDGF to instigate and maintain control over the actin–myosin‐based contractile system in Swiss 3T3 fibroblasts. The PDGF induced protein destabilization through the regulation of hnRNP‐K controlled ubiquitin ‐ligase translation identifies a novel pathway by which external stimuli can regulate phenotypic development through rapid, organelle‐specific changes in the activity and stability of cytoskeletal regulators.


  • Combined affinity labelling and mass spectrometry analysis of differential cell surface protein expression in normal and prostate cancer cells

    by Claire Hastie, Malcolm Saxton, Akunna Akpan, Rainer Cramer, John R Masters, Soren Naaby-Hansen

    Differences in the expression of cell surface proteins between a normal prostate epithelial (1542-NP2TX) and a prostate cancer cell line (1542-CP3TX) derived from the same patient were investigated. A combination of affinity chromatographic purification of biotin-tagged surface proteins with mass spectrometry analysis identified 26 integral membrane proteins and 14 peripheral surface proteins. The findings confirm earlier reports of altered expression in prostate cancer for several cell surface proteins, including ALCAM/CD166, the Ephrin type A receptor, EGFR and the prostaglandin F2 receptor regulatory protein. In addition, several novel findings of differential expression were made, including the voltage-dependent anion selective channel proteins Porin 1 and 2, ecto-5'-nucleotidase (CD73) and Scavenger receptor B1. Cell surface protein expression changed both qualitatively and quantitatively when the cells were grown in the presence of either or both interferon INF and INF. Costimulation with type I and II interferons had additive or synergistic effects on the membrane density of several, mainly peripherally attached surface proteins. Concerted upregulation of surface exposed antigens may be of benefit in immuno-adjuvant-based treatment of interferon-responsive prostate cancer. In conclusion, this study demonstrates that differences in the expression of membrane proteins between normal and prostate cancer cells are reproducibly detectable following vectorial labelling with biotin, and that detailed analysis of extracellular-induced surface changes can be achieved by combining surface-specific labelling with high-resolution two-dimensional gel electrophoresis and mass spectrometry.


  • Open Access

    Differential protein synthesis and expression levels in normal and neoplastic human prostate cells and their regulation by type I and II interferons

    by Kohji Nagano, John R Masters, Akunna Akpan, Alice Yang, Steve Corless, Chris Wood, Claire Hastie, Marketa Zvelebil, Rainer Cramer, Soren Naaby-Hansen

    Protein expression and de novo synthesis in normal and prostate cancer cell lines derived from the same patient were compared by proteomic analysis, and the effects of INFα and INFγ (INF=interferon) determined. The expressions of several INF-inducible proteins, including MxA, Nmi, PA28a and IFP53, were downregulated in the cancer cells. INFγ induced a more than twofold increase or decrease in the synthesis rates of almost twice as many proteins in the cancer cell line. The positive regulator of INF-induced transcription ISGF3γ was upregulated in the cancer cells and inversely regulated by INFα and INFγ in the normal and cancer cells. Moreover, ISGF3γ's induction by INFγ in the cancer cells was more enhanced by simultaneous stimulation with EGF, than its induction in the normal cells. In all, 31 differentially regulated proteins were identified by mass spectrometry analysis, several of which are involved in chaperone-assisted protein folding in the endoplasmic reticulum (ER) or in regulated protein degradation. Our results suggest that the exclusion of proteins by the ER quality control system, crosstalk between the EGF- and INF-induced signalling pathways and the regulation of INF-inducible genes are all altered in the prostate cancer cells. The combination of upregulated activity in the growth-promoting PI3K/Akt pathway, suppression of Nmi and overexpression of hnRNP-K and c-myc proteins may explain why the prostate cancer cells were found to be more resistant to the growth inhibitory effects of INFγ.


  • RNAi and 2DE, a promising combination for analysis of phospho-signalling and substrate identification

    by Sophia Khanna, Gayathri D. Warnasuriya, Julian Downward, Soren Naaby-Hansen